The Future of Healthcare Marketing: Lessons from the World of CPG.

Marketers in every industry face a twofold challenge today: increasing demands to quantify the ROI of every dollar spent, as well as demands for a simpler, more targeted message delivered through an increasingly complex array of media channels and touchpoints.

There is an oft-repeated trope that Pharma marketing seems to lag 3-5 years behind that of our colleagues promoting less-regulated products. In thinking about the likely future state of healthcare marketing, this lag is a huge opportunity for our industry. We’re all familiar with the demand for “innovative but proven” tactics, and one interesting approach to satisfying that demand may be to leverage marketing trends and tactics from outside the Pharma industry. Yes, there are industry-specific limitations, but other regulated industries have kept up with CPG – it’s arguable that Geico, for example, has moved insurance marketing from a laggard to a bellwether – and the next few years may be Pharma’s opportunity to shine.

One obvious challenge is the sheer volume of innovations that have impacted CPG marketers over the past five years. LUMA Partners, in their annual compilation of “Ad Tech” logos, has moved from one ecosystem chart in 2010 to no less than 15 full tabloid-size posters of potential marketing tools that a brand or company might adopt in 2016.

Faced with this plethora of options, it is useful to pull back and look for an underlying trend: is there one business objective is driving the vast majority of these innovations? A cursory summary of recent marketing consulting company white papers easily identifies a single overriding theme: “Optimizing the Customer Experience.” Adobe’s 2016 Digital Trends Report claims: “It’s official. Customer experience is in charge. In 2014, it emerged as a top priority for marketers. In 2015, it gained momentum. Now, in 2016, it’s so important, it pulls other priorities into its orbit.” McKinsey goes further in quantifying the benefits of improving the customer journey: “Our research indicates that for every 10-percentage-point uptick in customer satisfaction, a company can increase revenues 2 percent to 3 percent. At a time when the customer-satisfaction scores of top-quartile institutions can exceed those of bottom-quartile players by as much as 30 to 40 percentage points, the financial payoff from best-in-class CX can be significant indeed.”

Now the concept of optimizing our customer’s experience is not new to Pharma. Given CX’s dominance in the world of CPG, the value that companies like Disney (MagicBand), Google (search), and Apple (every product) have derived from building frictionless experiences, and the predominance of “user-centricity” advocates at every consulting firm, it’s no surprise that Big Pharma has jumped on the bandwagon. For example, J&J has adopted a mantra of “connected experiences,” which they define as engaging “our consumer at the right time, with the right message, on the right device with consistency and relevancy across channels in a best-in-class user experience.” And while there is no objection to these admirable goals, we should ask three questions:
1) How realistic is this “best-in-class consumer experience” in pharma, given the complexity of the healthcare system – both logistically and in terms of the regulatory environment?
2) Given the huge range of tactical options, where do we start?
3) How much of the current focus of advanced CPG marketing (shareable video content, retargeting, “programmatic native”) will ever be relevant to Pharma?

I suspect the right answers are: any improvement is welcome, start anywhere you can, and maybe. The only viable approach is to discuss options in advance with our friends in Regulatory, then test, measure, and look for verifiable and repeatable incremental gains. Pharma is not alone in needing to work to perfect its customer experience. Forrester notes that “despite progress in journey initiatives, there’s still a long way to go: Only 5 percent of customer journey professionals feel they have a complete view of their customers’ journeys.” So there is no “perfect” model – this is an evolving discipline.

But there are some guiding principles – derived from software development – that may help get us on the right path. My contention is that most marketing and communications enhancements in the pursuit of the perfect customer experience over the last ten years fall into three inter-related areas, all of which can be applied to build better Pharma marketing…

Data Driven
Marketing is a discipline that increasingly relies on an ever more granular sea of big and small data, from qualitative (interviews, sentiment, and eye-tracking studies) to quantitative (the mass of customer data triggered by almost every interaction with a brand, both offline and online). In response to this data, in general, the industry has been moving over the last 25 years from full-spectrum broadcast, to segmentation, and is currently laser-focused on personally targeted messaging. Every year there have been more data offerings and more ways to utilize that data, to the point of “information overload paralysis”: an inability to release anything without testing and re-testing, sometimes to the detriment of any innovation. The path forward is to develop methodologies for identifying the “actionable” portions of the data: those levers that might move consumer sentiment, those aspects of the experience that are critical factors to a brand’s success that might actually move the needle for our targets. Measure real-world outcomes against data trends.

Responsive
It’s critical to ensure that our communications are accessible and relevant to users: more than just optimized for the device they are using (mobile), we must enable intra-customer recommendations (social), and modify our message based on the context in which they are viewing our materials (local). Further, we should be working to move from a mind-set of “what do we want our customer to hear?” to “what does our customer want us to tell them?” We must look at how our targets consume and amplify media – VR/AR may be the next step in a progression from text to images to video, but a portion of digital consumption/interaction is also becoming less “rich” – from wearables to the Internet of Things and even the rise of voice-controlled media with Siri and Alexa. Give the user what they need, when they need it. Nothing more, nothing less.

Agile
The prevailing approach in CPG is that rather than trying to use all possible data and all possible tactics, it’s more productive to get something out into the market, see how it performs, and leverage real-world data to identify friction points and incrementally optimize the customer journey. This agile approach allows us to be responsive to changing user and stakeholder needs, hard data such as analytics from each deployment, and changing conditions in the marketplace – including system and browser updates, for example, or expansion to include a new product. Each asset should be designed to leverage data and feedback generated by any preceding deployed assets. In this way, the program becomes iteratively more focused in terms of targeting, messaging, and delivery methodology.

A best practice when considering future technology recommendations is to examine the past, be sure to understand the present, and use these data points to extrapolate the future. As digital marketers in the highly regulated Pharma industry, we must take legal, medical, and even federal regulatory approvals in this consideration, and anticipate that some CPG tactics may step outside the comfort zone of our industry. But if our single-minded goal with every project is to provide the most valuable, useful (and balanced) user experience possible for the end user, we will be on the right path.

- David Cherry, Chief Digital Officer

Posted in Leadership, Technology, Thoughts | Leave a comment
Share |

Celebrating 75 years of creativity

S&H Group continues to celebrate its 75th year at “Off Label,” an exhibition of Sudler staff creative efforts. The show, hosted last week at Rogue Space Gallery, 26th St, New York City, provided all employees with the opportunity to share their creative talents beyond what they do at work on a daily basis. The collection included over 50 paintings, photographs, mixed media work, and sculpture. The work from the gallery event can be accessed at www.Offlabel.gallery.

Posted in Creative, News, Social Media, Thoughts | Leave a comment
Share |

Sudler featured in The Drum’s 2016 healthcare supplement

Sudler’s Julian Wakeley, Chris Duffey, and David Cherry were all interviewed on various aspects of the healthcare revolution in The Drum’s “Hacking Health” supplement, distributed to coincide with the Cannes Health Lions. Download a PDF of the issue here.

Posted in Creative, Leadership, Marketing, Thoughts | Leave a comment
Share |

Be Live Shortlisted for 2016 Cannes Healthcare Lion

Very pleased to see our project with Pfizer LATAM shortlisted at Cannes Healthcare.

Posted in Leadership, News, Successful Test, Technology | Leave a comment
Share |

Sudler highlighted in Pharma3D ebook from Google

We were very pleased to see Sudler and the Pfizer Lyrica BeLive wearable program featured as a case study for the future of pharma marketing in Google’s new Pharma3D book, which launched last week. The program is featured in Chapter 6 of the eBook. Lovely work from our Mexico and NYC offices, supporting the Pfizer LATAM team.

Posted in Leadership, News, Successful Test, Technology, Thoughts | Leave a comment
Share |

Do Apple Watch + HealthKit provide a complete Health Tracking System?

Our very own digital strategist, Mark Davis, has been experimenting with the Apple Watch and a variety of other health tracking tools, and provides some insights into his impressions of the usefulness of the Apple system for health tracking on his Medium account. Interesting reading.

Posted in Leadership, News, Technology, Thoughts | Leave a comment
Share |

Onsite SEO in 2015

Rand Fish of Moz has published a truly elegant summary of the current state of SEO and the Google search algorithm on SlideShare. Well worth a read for anyone building sites, in any industry.

Posted in SEO, Technology, Thoughts | Leave a comment
Share |

What does it take to be a great creative?

Rob Rogers interviewed by The Drum

Posted in Creative, Leadership, Thoughts | Leave a comment
Share |

Rob Rogers is on a mission

Our CEO is headed to Cannes for the Health Lions on June 19-20 with a mission to prove that not all pharma creative is flat…

Rob Rogers is Captain Cannes

Posted in Creative, Leadership, Marketing, Thoughts | Leave a comment
Share |

Sudler New York and POSSIBLE Mobile Announce Apple ResearchKit Collaboration

Sudler & Hennessey is pleased to announce an important collaboration with POSSIBLE Mobile on Apple’s new ResearchKit, which capitalizes on the extensive iPhone user base to help recruit people for medical studies. Both companies will collaborate on the development of ResearchKit apps to enable researchers to expand their clinical trials and monitor large patient populations. POSSIBLE Mobile’s team of development experts is responsible for technical evaluations and technical work, while Sudler’s team of pharma experts will determine the healthcare strategy. Read the full press release here.

Posted in Apps, Leadership, Mobile, Technology, Thoughts | Leave a comment
Share |